発表論文

2018年

Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial.

Ohsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, Fukai Y, Murakami T, Koga Y, Goto YI, Ohta S, Sunada Y, KN01 Study Group.

Journal of neurology, neurosurgery, and psychiatry  2018

 

Changes in oxidative stress severity and antioxidant potential during muscle atrophy and reloading in mice.

Katsuta W, Aihara M, Hirose N, Saito F, Hagiwara H

Journal of physical therapy science 30(1) 42-46 2018

 

2017年

Cleavage of a-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9.

Fukai Y, Ohsawa Y, Ohtsubo H, Nishimatsu SI, Hagiwara H, Noda M, Sasaoka T, Murakami T, Sunada Y

Biochemical and biophysical research communications 492(2) 199-205 2017

 

A new model of skeletal muscle atrophy induced by immobilization using a hook-and-loop fastener in mice.

Aihara M, Hirose N, Katsuta W, Saito F, Maruyama H, Hagiwara H

Journal of physical therapy science 29(10) 1779-1783 2017

 

Pax3 preserves myoblasts undifferentiated by suppressing MyoD and enhancing cell cycle regulators

Huang S, Hagiwara H, Shimizu T, Wang W

International Journal of Clinical and Experimental Pathology 10(3) 3043-3051 2017

 

2015年

The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.

Ohsawa Y, Takayama K, Nishimatsu S, Okada T, Fujino M, Fukai Y, Murakami T, Hagiwara H, Itoh F, Tsuchida K, Hayashi Y, Sunada Y

PLoS ONE 10(7) e0133713 2015